Temporal trends and socioeconomic determinants of cytoreductive nephrectomy (CN) utilization for metastatic renal cell carcinoma (mRCC) in the United States (US).

被引：0
|
作者：
Esagian, Stepan M.
Msaouel, Pavlos
Karam, Jose A.
Gartrell, Benjamin
Makrakis, Dimitrios
机构：
[1] Albert Einstein Coll Med, NYC Hlth Hosp Jacobi, Dept Med, Bronx, NY USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[4] Montefiore Einstein Canc Ctr, Bronx, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.447
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Role of cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC).
    Ghatalia, Pooja
    Handorf, Elizabeth A.
    Deng, Mengying
    Zibelman, Matthew R.
    Abbosh, Philip
    Anari, Fern
    Greenberg, Richard E.
    Viterbo, Rosalia
    Chen, David
    Smaldone, Marc C.
    Kutikov, Alexander
    Geynisman, Daniel M.
    Uzzo, Robert Guy
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Preoperative sorafenib (Sor) and cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC)
    Finelli, A.
    Horgan, A. M.
    Evans, A.
    Kim, T. K.
    Durrant, K.
    Yap, S.
    Cassol, C. A.
    Dubinski, W.
    Fleshner, N.
    Jewett, M. A. S.
    Joshua, A. M.
    Sridhar, S. S.
    Zlotta, A.
    Knox, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] POPULATION-BASED TRENDS AND OUTCOMES FOR CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA IN THE UNITED STATES
    Wiesen, Brett
    Achua, Justin
    Warren, Adam
    Gershman, Boris
    Eule, Corbin
    Kim, Simon
    JOURNAL OF UROLOGY, 2024, 211 (05): : E849 - E850
  • [4] External validation of a prediction model of survival after cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC).
    Bex, Axel
    van Werkhoven, Erik D.
    Noe, Allard
    Karam, Jose A.
    Matin, Surena F.
    Margulis, Vitaly
    Stewart, Grant
    Staehler, Michael D.
    Wood, Christopher G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [5] Outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with systemic therapy without cytoreductive nephrectomy (CN)
    Richey, S. L.
    Culp, S. H.
    Wood, C. G.
    Corn, P. G.
    Jonasch, E.
    Tannir, N. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Outcome of patients with metastatic renal cell carcinoma (mRCC) treated with targeted therapy (TT) without cytoreductive nephrectomy (CN)
    Richey, S. L.
    Culp, S. H.
    Jonasch, E.
    Corn, P. G.
    Pagliaro, L. C.
    Matin, S. F.
    Wood, C. G.
    Tannir, N. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] CABOPRE: A phase II study of cabozantinib (cabo) prior cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC)
    De Velasco, G.
    Alonso-Gordoa, T.
    Rodriguez-Moreno, J. F.
    Duran, I.
    Carretero-Gonzalez, A.
    Martin-Soberon, M.
    Gutierrez Banos, J. L.
    Guerrero-Ramos, F.
    Duenas, M.
    Castellano Gauna, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S698 - S699
  • [8] Cytoreductive nephrectomy in advanced or metastatic renal cell carcinoma (mRCC): In the era of targeted strategies
    Toutziaris, C.
    Lontovinis, L.
    Tsoukalas, N.
    Radopoulos, D.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 : S26 - S26
  • [9] PARTIAL NEPHRECTOMY VERSUS RADICAL NEPHRECTOMY FOR NON-METASTATIC RENAL CELL CARCINOMA: UTILIZATION TRENDS IN THE UNITED STATES
    Sun, Maxine
    Jeldres, Claudio
    Abdollah, Firas
    Liberman, Daniel
    Schmitges, Jan
    Djahangirian, Orchid
    Ismail, Salima
    Zorn, Kevin
    Shariat, Shahrokh F.
    Perrotte, Paul
    Karakiewicz, Pierre I.
    JOURNAL OF UROLOGY, 2011, 185 (04): : E219 - E219
  • [10] Utilization of Partial Cytoreductive Nephrectomy in Patients with Metastatic Renal Cell Carcinoma
    Hauser, Nicholas
    Giakas, Julian
    Robinson, Hunter
    Davaro, Facundo
    Hamilton, Zachary
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
12345